IVERIC bio is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. We are particularly interested in adeno-associated virus (AAV) gene therapy delivery vehicles. AAV vectors have a well-documented safety record for gene delivery in the eye, targeting specific cells of interest, thereby minimizing off-target side effects. Orpha...
IVERIC bio is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. We are particularly interested in adeno-associated virus (AAV) gene therapy delivery vehicles. AAV vectors have a well-documented safety record for gene delivery in the eye, targeting specific cells of interest, thereby minimizing off-target side effects. Orphan inherited retinal diseases are generally caused by many different mutations within a single gene. Our strategy is to develop mutation independent treatment options to potentially treat the entire class of a disease.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.